DEZAWA GOLDEN IV
Live / Applied — Non-final action mailed (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 12 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79437883
- Mark type
- Stylized text
- Filed
- 12 Sept 2025
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Anti-aging cosmetic preparations; anti-aging cream; anti-aging creams; anti-aging creams for cosmetic purposes; anti-aging creams for sun protection for the face and body; anti-aging masks for cosmetic purposes; anti-aging moisturisers; anti-aging moisturizers; anti-aging serums for cosmetic purposes; anti-aging serums for cosmetic use; anti-aging serums for sensitive skin; anti-aging skincare preparations; anti-aging sun protection creams for the face and body.
- Class 005 — Pharmaceuticals: Cells for medical purposes; cells for medical use; cellular function activating agents for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; cellulose for pharmaceutical purposes; chemicals for cell separation and cultivation for medical or veterinary purposes; chemicals for separating and cultivating cells for medical or veterinary purposes; living cells for medical purposes; living cells for medical use; pharmaceutical compositions containing stem cells for the treatment of diseases; pharmaceutical preparations containing stem cells; pharmaceutical preparations for activating cellular function; stem cells for medical purposes; autoinjectors prefilled with pharmaceutical preparations; immunological products for intravenous injections; injectable medicinal solutions; injectable solutions for medical purposes; injectable solutions for use in inhibiting peristalsis for medical purposes; pharmaceutical preparations sold in pre-filled injectors; intravenous fluids used for the delivery of pharmaceutical preparations; intravenous solutions for medical purposes; immunosuppressive pharmaceutical preparations; pharmaceutical preparations for the treatment of cystic fibrosis; glycerophosphates; phosphates for pharmaceutical purposes; cardiovascular agents for medical purposes; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; cardiovascular preparations; cardiovascular treatment preparations; drugs for the treatment of cardiovascular diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention of cardiovascular disorders; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; anti-ulcer agents; pharmaceutical preparations being antiulceratives; pharmaceutical preparations for the treatment of chronic liver diseases.
- Class 042 — Scientific and technological services: Analysis of stem cells for medical research; cell culture services for scientific and research purposes, for others; culturing of cells for scientific research purposes; research and development in the field of microorganisms and cells; research and development services in the field of microorganisms and cells; research in the field of cell engineering technology; research of induced pluripotent stem cells; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research; stem cell research services.
- Class 044 — Medical, beauty and agricultural services: Human cell bank services; medical services relating to the removal, treatment and processing of stem cells; stem cell bank services; stem cell therapy services; medical services relating to the removal, treatment and processing of human cells; storage of human cells; storage of stem cells [stem cell bank services]; providing on-line information relating to the prevention of cardiovascular disease and strokes; medical services relating to the removal, treatment and processing of bone marrow; medical services relating to the removal, treatment and processing of umbilical cord blood; providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the Internet; health care services for treating Alzheimer's disease.
Owner
Prosecution history
- 05 Feb 2026 — REFUSAL PROCESSED BY IB
- 22 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 22 Jan 2026 — REFUSAL PROCESSED BY MPU
- 18 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 17 Dec 2025 — NON-FINAL ACTION WRITTEN
- 11 Dec 2025 — ASSIGNED TO EXAMINER
- 01 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 01 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB